During the past decade, Debreceni Egyetem conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 12 clinical trials were completed, i.e. on average, 38.7% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 10 clinical trials were completed. i.e. 52.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Debreceni Egyetem" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Abivax S.A." with 2 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Debreceni Egyetem" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Centessa Pharmaceuticals plc" with 1 trials as a collaborator and "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Debreceni Egyetem" are "Ulcerative Colitis" (3 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "ADPKD" (1 trials), "Adenoviral Conjunctivitis" (1 trials) and "Alopecia Areata" (1 trials). Many other conditions were trialed in "Debreceni Egyetem" in a lesser frequency.

Most popular intervention types in "Debreceni Egyetem" are "Drug" (31 trials), "Biological" (3 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Gemcitabine" (2 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "PVP-I 0.6%" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Debreceni Egyetem" are 30 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Debreceni Egyetem". undefined are not yet recruiting, 10 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Debreceni Egyetem, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Debreceni Egyetem, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Debreceni Egyetem has several departments that took part in Clinical trials: "Debreceni Egyetem, Klinikai Kozpont, Onkologiai Klinika" - 17 trials, "University of Debrecen Medical and Health Science Center Department of Anesthesiology and Intensive Care" - 10 trials, "Debreceni Egyetem Klinikai Kozpont ; Department of Oncology" - 10 trials, "Debreceni Egyetem Klinikai Központ Kardiológiai és Szívsebészeti Klinika" - 4 trials, "Debrecen University Clinical Center, Orthopedic Clinic" - 4 trials, "Uni of Debrecen; 2Nd Clinic of Internal Medicine" - 4 trials, "DE KK Ortopediai Klinika" - 3 trials, "University of Debrecen, Medical and Health Science Center" - 31 trials, "Debreceni Egyetem Klinikai Kozpont Infektologiai Klinika" - 3 trials, "Debreceni Egyetem Orvos- és Egészségtudományi Centrum; Belgyógyászati Intézet, Reumatológiai Tanszék" - 3 trials, "Institute of Infectology, University of Debrecen" - 2 trials, "Kenezy Hospital Institute of Clinical Pharmacology" - 2 trials, "University of Debrecen Medical Center Department of Clinical Immunology" - 2 trials, "University of Debrecen, Medical and Health Science Center, Department of Pulmonology" - 2 trials, "Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Hematologia" - 2 trials